Reduction of buffalo hump by switching to amprenavir in an HIV-infected patient.
Khanlou
H
H
Adair
M
M
Farthing
C
C
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002219:Carbamates; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D019469:Indinavir / Q000009:adverse effects*; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D013449:Sulfonamides / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir; D019469:Indinavir